Collplant Biotechnologies Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CLGN Nasdaq 8731 https://www.collplant.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Collplant Biotechnologies Ltd

CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023 - Nov 29th, 2023 12:00 pm
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Nov 9th, 2023 1:00 pm
Will CollPlant Biotechnologies (NASDAQ:CLGN) Spend Its Cash Wisely? - Nov 3rd, 2023 10:10 am
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler - Nov 1st, 2023 11:00 am
Shareholders in CollPlant Biotechnologies (NASDAQ:CLGN) are in the red if they invested three years ago - Oct 5th, 2023 12:14 pm
CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative - Sep 21st, 2023 11:00 am
CollPlant to Present at the H.C. Wainwright Annual Growth Conference - Sep 5th, 2023 11:00 am
Results: CollPlant Biotechnologies Ltd. Beat Earnings Expectations And Analysts Now Have New Forecasts - Aug 27th, 2023 12:18 pm
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million - Aug 24th, 2023 11:00 am
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Aug 9th, 2023 12:00 pm
CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement - Jun 26th, 2023 11:00 am
CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update - May 24th, 2023 11:00 am
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - May 2nd, 2023 1:00 pm
Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs - Apr 4th, 2023 12:26 pm
Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update - Mar 29th, 2023 11:00 am
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Mar 14th, 2023 11:00 am
CollPlant Issues Letter to Shareholders - Jan 24th, 2023 12:00 pm
CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives - Jan 4th, 2023 12:00 pm
CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form - Jan 3rd, 2023 12:00 pm
We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth - Dec 12th, 2022 2:50 pm